Form4insider filings, from the source

SEC Form 4 · accession 0000914190-16-000741

Arno Therapeutics, Inc · ARNI

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Aug 15, 2016
Accepted (ET)
Aug 17, 2016 · 6:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001195116

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Aug 15, 2016P$0714,285—A2,262,838IArie S. Belldegrun, M.D. Inc. Profit Sharing Plan
Common Stockholding———3,115D
Common StockF3holding———858,094ILeumi Overseas Trust Corp. Ltd. as TTEE of the BTL Trust
Common StockF4holding———254,887ILeumi Overseas Trust Corp. Ltd. as TTEE of the Tampere Trust
Common StockF5holding———379,294IBelldegrun Family Trust
Common StockF6holding———174,644IMDRB Partnership, L.P.

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
2016 Series F Warrants (right to buy)F1,F2$0.4375Aug 15, 2016P357,142AAug 15, 2016Aug 15, 2021Common Stock357,142357,142I

Explanation of responses